Maynard Um
-
-
-
-
-
-
-
Edgewise Therapeutics (EWTX) PT Raised to $51 at Guggenheim
-
-
-
-
-
-
-
Edgewise Therapeutics (EWTX) PT Lowered to $48 at RBC Capital
-
-
-
-
-
-
-
Edgewise reports sevasemten stabilized function in Becker dystrophy study
-
-
-
-
-
-
-
Edgewise Therapeutics (EWTX) PT Lowered to $32 at Wedbush
-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Edgewise Therapeutics (EWTX)
-
-
-
-
-
-
-
Piper Sandler Sees 'Meaningful Upside Opportunities' for Edgewise Therapeutics (EWTX)
-
-
-
-
-
-
-
Edgewise Therapeutics Inc. (EWTX) Announces Pricing of $200M Underwritten Offering of Common Stock
-
470,361 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


